Immune responses that dictate metastatic spread in breast cancer

Hertzog, Paul (Primary Chief Investigator (PCI))
Parker, Belinda S. (Partner Investigator (PI))

Hudson Institute - Centre for Innate Immunity and Infectious Disease

Project: Research

2 Article
1 Review Article

3 results

2019

Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC
Brockwell, N. K., Rautela, J., Owen, K. L., Gearing, L. J., Deb, S., Harvey, K., Spurling, A., Zanker, D., Chan, C. L., Cumming, H. E., Deng, N., Zakhour, J. M., Duivenvoorden, H. M., Robinson, T., Harris, M., White, M., Fox, J., Ooi, C., Kumar, B., Thomson, J., & 7 othersPotasz, N., Swarbrick, A., Hertzog, P., Molloy, T. J., O’Toole, S., Ganju, V. & Parker, B. S., 1 Dec 2019, In: npj Precision Oncology. 3, 1, 13 p., 21.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

26 Citations (Scopus)
2017

Neoadjuvant interferons: Critical for effective PD-1–based immunotherapy in TNBC
Brockwell, N. K., Owen, K. L., Zanker, D., Spurling, A., Rautela, J., Duivenvoorden, H. M., Baschuk, N., Caramia, F., Loi, S., Darcy, P. K., Lim, E. & Parker, B. S., 1 Oct 2017, In: Cancer Immunology Research. 5, 10, p. 871-884 14 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

59 Citations (Scopus)
2016

Antitumour actions of interferons: Implications for cancer therapy
Parker, B. S., Rautela, J. & Hertzog, P. J., 1 Mar 2016, In: Nature Reviews Cancer. 16, 3, p. 131-144 14 p.
Research output: Contribution to journal › Review Article › Research › peer-review

648 Citations (Scopus)